Cisplatin resistance in gastric cancer cells is involved with GPR30‐mediated epithelial‐mesenchymal transition

Cisplatin is the major chemotherapeutic drug in gastric cancer, particularly in treating advanced gastric cancer. Tumour cells often develop resistance to chemotherapeutic drugs, which seriously affects the efficacy of chemotherapy. GPR30 is a novel oestrogen receptor that is involved in the invasio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaofeng, Xu, Zhiyuan, Sun, Jiancheng, Lv, Hang, Wang, Yiping, Ni, Yixiu, Chen, Shangqi, Hu, Can, Wang, Lijing, Chen, Wei, Cheng, Xiangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131920/
https://www.ncbi.nlm.nih.gov/pubmed/32052561
http://dx.doi.org/10.1111/jcmm.15055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131920/
https://www.ncbi.nlm.nih.gov/pubmed/32052561
http://dx.doi.org/10.1111/jcmm.15055

Ejemplares similares